On January 13, 2025, Roivant Science Ltd made two major purchases, $336.9 million for each. The first purchase was the shares of Immunovant Inc. (NASDAQ:IMVT) and the companys own stock ROIV.

On January 13, 2025, Roivant Science Ltd made two major purchases, $336.9 million for each. The first purchase was the shares of Immunovant Inc. (NASDAQ:IMVT) and the companys own stock ROIV. In the ...

JPMorgan Chase & Co. grew its holdings in shares of Roivant Sciences by 4.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 822,582 shares of the company’s stock worth $9,493,000 after ...

In this article, we are going to take a look at where Roivant Sciences Ltd. (NASDAQ:ROIV) against other firms end 2024 stronger with impressive gains. A lackluster trading persisted throughout the ...

Bank of America Securities analyst Chi Meng Fong maintained a Hold rating on Roivant Sciences (ROIV – Research Report) today. The company’s shares closed yesterday at $10.74. Discover ...

Scipher Medicine, a leader in precision medicine for autoimmune diseases, and Roivant, a global biopharmaceutical company that aims to improve the lives of patients by accelerating the development ...

In this article, we are going to take a look at where Roivant Sciences Ltd. (NASDAQ:ROIV) stands against the other best medical stocks under $20. The medical industry plays a crucial role in ...

In other Roivant Sciences news, COO Eric Venker sold 100,000 shares of the stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $11.32, for a total value ...

We recently compiled a list of the Best Medical Stocks To Buy Under $20. In this article, we are going to take a look at where Roivant Sciences Ltd. (NASDAQ:ROIV) stands against the other best medical ...

WALTHAM, Mass.--(BUSINESS WIRE)--Scipher Medicine, a leader in precision medicine for autoimmune diseases, and Roivant, a global biopharmaceutical company that aims to improve the lives of ...

Eric Venker, President & COO at Roivant Sciences ROIV, reported a large exercise of company stock options on January 1, according to a new SEC filing. What Happened: A Form 4 filing with the U.S ...

We recently published a list of 10 Firms End 2024 Stronger With Impressive Gains. In this article, we are going to take a look at where Roivant Sciences Ltd. (NASDAQ:ROIV) against other firms end 2024 ...